PTGX - Protagonist Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PTGX is currently covered by 4 analysts with an average price target of $82.61. This is a potential upside of $17.31 (26.51%) from yesterday's end of day stock price of $65.3.

Protagonist Therapeutics's activity chart (see below) currently has 107 price targets and 99 ratings on display. The stock rating distribution of PTGX is 94.44% BUY and 5.56% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 83.92% with an average time for these price targets to be met of 507.14 days.

Highest price target for PTGX is $80, Lowest price target is $57, average price target is $68.25.

Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 17-Sep-2025. First documented stock forecast 06-Sep-2016.

Currently out of the existing stock ratings of PTGX, 17 are a BUY (94.44%), 1 are a HOLD (5.56%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$80

$15.17 (23.40%)

$80

21 days ago
(17-Sep-2025)

28/33 (84.85%)

$20.78 (35.09%)

327

Buy

$69

$4.17 (6.43%)

$61

2 months 1 days ago
(07-Aug-2025)

11/12 (91.67%)

$18.04 (35.40%)

170

Buy

$57

$-7.83 (-12.08%)

$53

7 months 4 days ago
(04-Mar-2025)

5/5 (100%)

$18.34 (47.44%)

106

Hold

$67

$2.17 (3.35%)

$51

10 months 16 days ago
(22-Nov-2024)

5/5 (100%)

$20.54 (44.21%)

584

Buy

$35

$-29.83 (-46.01%)

$35

2 years 3 months 5 days ago
(03-Jul-2023)

6/10 (60%)

$12.69 (56.88%)

1001

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PTGX (Protagonist Therapeutics) average time for price targets to be met?

On average it took 507.14 days on average for the stock forecasts to be realized with a an average price target met ratio 83.92

Which analyst has the current highest performing score on PTGX (Protagonist Therapeutics) with a proven track record?

YASMEEN RAHIMI

Which analyst has the most public recommendations on PTGX (Protagonist Therapeutics)?

Yasmeen Rahimi works at PIPER SANDLER and has 4 price targets and 2 ratings on PTGX

Which analyst is the currently most bullish on PTGX (Protagonist Therapeutics)?

Tim Chiang with highest potential upside - $47.4

Which analyst is the currently most reserved on PTGX (Protagonist Therapeutics)?

Joseph Schwartz with lowest potential downside - -$34.83

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?